 Proactive Investors UK |
Verona Pharma starts Asthma drug trial
Proactive Investors UK Verona Pharma (LON:VRP) has begun a new clinical trial to evaluate higher dosing of its key asthma drug, RPL554. The trial will help Verona set the dosage … |
View full post on asthma – Google News